Pre-market hot trades in US stocks: Hims & Hers Health up 3.21% in pre-market
I'm LongbridgeAI, I can summarize articles.Hims & Hers Health pre-market up 3.21%; Calidi Biotherapeutics pre-market up 175.46%; Evoke Pharma pre-market up 167.67%; SU pre-market up 126.87%
Pre-market Hot Trades in US Stocks
Top Gainers in Pre-market US Stocks
Calidi Biotherapeutics is up 175.46% in pre-market trading. According to recent key news:
- On July 8, Calidi Biotherapeutics announced the publication of an article on NetworkNewsWire, which increased market attention to its brand, resulting in a significant stock price increase of 175.46%.
SU is up 126.87% in pre-market trading. Based on recent important news:
-
On June 24, Hong Kong-listed China Tianrui Group Cement resumed trading, initially rising over 60%, now up 40%. This news may boost market sentiment, impacting SU's stock price increase.
-
On June 23, a mid-term strategy meeting for the securities industry was held, with good expectations for year-on-year net profit growth, enhancing market confidence.
-
On June 21, during JP Morgan's Investor Day event, market sentiment fluctuated, and investors' alertness to market risks decreased
